Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04317105 |
|---|---|
| Brief Title: | Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN |
| First Submitted : | March 20, 2020 |
| First Submitted that Met QC Criteria : | March 20, 2020 |
| First Posted : | March 23, 2020 |
| Last Update Submitted that Met QC Criteria : | January 12, 2021 |
| Last Update Posted : | January 13, 2021 |